株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

心血管系医薬品の世界市場:将来予測

Cardiovascular Drugs Global Market Report 2020-30: Covid 19 Impact and Recovery

発行 The Business Research Company 商品コード 531324
出版日 ページ情報 英文
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=108.53円で換算しております。
心血管系医薬品の世界市場:将来予測 Cardiovascular Drugs Global Market Report 2020-30: Covid 19 Impact and Recovery
出版日: 2020年05月19日 ページ情報: 英文
概要

当レポートでは、世界の心血管疾患向け医薬品の市場構造・動向について分析し、市場の主な特徴・構造や、全体的な市場規模・成長率の動向見通し (過去・今後5年間分)、種類別・地域別・主要国の詳細動向、主なマクロ経済指標との対比、主要企業のプロファイル、近年の主な傾向などを調査しております。

第1章 エグゼクティブサマリー

第2章 レポート構造

第3章 市場の特徴:心血管系医薬品

  • 市場の定義
  • 主な区分

第4章 心血管系医薬品市場:製品分析

  • 主要製品/サービス
  • 主な機能と差別化要因
  • 開発中の製品

第5章 心血管系医薬品市場のサプライチェーン

  • サプライチェーン
  • 流通
  • 最終顧客

第6章 心血管系医薬品市場の顧客情報

  • 顧客の選好
  • 最終用途市場の規模と成長率

第7章 心血管系医薬品市場の傾向と戦略

第8章 心血管系医薬品市場:市場規模・成長率

  • 市場規模・成長率:実績値 (金額ベース)
  • 市場規模・成長率:予測値 (金額ベース)
    • 市場促進要因
    • 市場抑制要因

第9章 心血管系医薬品市場:地域分析

  • 市場規模:地域別 (金額ベース、2018年)
  • 市場規模:地域別 (2014年~2022年)
  • 成長率・市場シェアの比較:地域別

第10章 心血管系医薬品市場の内訳

  • 世界の心血管系医薬品市場:種類別の内訳 (金額ベース、2014年~2022年)
    • 降圧薬
    • 脂血降下剤
    • 抗血栓薬
    • 他の心血管疾患向け薬剤(うっ血性心不全、抗不整脈薬、抗狭心症薬)

第11章 心血管系医薬品の市場指標

  • 心血管系医薬品の市場規模と対GDP割合 (世界全体、2014~2022年)
  • 心血管系医薬品:一人当たりの平均市場支出額 (世界全体、2014年~2022年)

第12章 アジア太平洋地域の心血管系医薬品市場

  • 市場概要
  • 市場規模:国別 (金額ベース、2018年)
  • 市場規模:実績値・予測値、国別 (2014~2022年)
  • 市場成長率と市場シェアの比較:国別 (2014~2022年)
  • 市場指標
    • 一人当たり平均支出額 (2014~2022年)
    • 高血圧有病率/心血管系医薬品市場 (2018年)
  • 種類別の市場区分 (金額ベース、2014~2022年)
  • 国別分析
    • 中国市場
    • オーストラリア市場
    • 香港市場
    • インド市場
    • インドネシア市場
    • 日本市場
    • マレーシア市場
    • ニュージーランド市場
    • フィリピン市場
    • シンガポール市場
    • 韓国市場
    • タイ市場
    • ベトナム市場

第13章 西欧の心血管系医薬品市場

  • 国別分析
    • オーストリア市場
    • ベルギー市場
    • デンマーク市場
    • フィンランド市場
    • フランス市場
    • ドイツ市場
    • アイルランド市場
    • イタリア市場
    • オランダ市場
    • ノルウェー市場
    • ポルトガル市場
    • スペイン市場
    • スウェーデン市場
    • スイス市場
    • 英国市場

第14章 東欧の心血管系医薬品市場

  • 国別分析
    • チェコ市場
    • ポーランド市場
    • ルーマニア市場
    • ロシア市場

第15章 北米の心血管系医薬品市場

  • 国別分析
    • カナダ市場
    • メキシコ市場
    • 米国市場

第16章 南米の心血管系医薬品市場

  • 国別分析
    • アルゼンチン市場
    • ブラジル市場
    • チリ市場
    • コロンビア市場
    • ペルー市場
    • ベネズエラ市場

第17章 中東の心血管系医薬品市場

  • 国別分析
    • サウジアラビア市場
    • イスラエル市場
    • トルコ市場
    • アラブ首長国連邦 (UAE) 市場

第18章 アフリカ心血管系医薬品市場

  • 国別分析
    • エジプト市場
    • ナイジェリア市場
    • 南アフリカ市場

第19章 心血管系医薬品市場の競争環境

  • 競争市場の概要
  • 市場シェア
  • 会社概要
    • Merck & Co
    • Sanofi S.A
    • Pfizer Inc
    • Bristol-Myers Squibb Company
    • Novartis AG

第20章 心血管系医薬品における主な企業合併・買収 (M&A)

章21:市場の背景事情:医薬品市場

  • 医薬品市場の特徴
  • 世界の医薬品市場の推移と予測:部門別の成長率 (2014~2022年)
  • 世界の医薬品市場:地域別 (金額ベース、2018年)
  • 世界の医薬品市場、2014年~2022年、地域別の歴史的および予測
  • 世界の医薬品市場、2014年~2022年、種類別のセグメンテーション、価値(10億ドル)

第22章 提言

  • 世界の心血管系医薬品市場 (2022年):成長国
  • 世界の心血管系医薬品市場 (2022年):成長部門
  • 世界の心血管系医薬品市場 (2022年):成長戦略

章23:付録

第24章 著作権と免責事項

目次

‘Cardiovascular Drugs Global Market Report 2020-30: Covid 19 Impact and Recovery ’ from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global cardiovascular drugs market as it emerges from the Covid 19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the cardiovascular drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Cardiovascular Drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider cardiovascular drugs market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the Covid 19 virus and forecasting its recovery.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The cardiovascular drugs market section of the report gives context. It compares the cardiovascular drugs market with other segments of the pharmaceutical drugs market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, cardiovascular drugs indicators comparison.

Scope

Markets Covered:

1) By Type: Anti-Hypertensive Drugs; Hypolipidemics; Anti Thrombotics; Other Drugs For Cardiovascular Diseases (Congestive Heart Failure, Anti-Arrhythmic And Anti-Anginal Drugs)

2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Others

3) By Route Of Administration: Oral; Parenteral; Others

4) By Drug Classification: Branded Drugs; Generic Drugs

5) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs

Companies Mentioned: Merck & Co; Sanofi S.A; Pfizer Inc; Bristol-Myers Squibb Company; Novartis AG

Metrics Covered: Number of Enterprises; Number of Employees

Countries: Argentina; Australia; Austria; Belgium; Brazil; Canada; Chile; China; Colombia; Czech Republic; Denmark; Egypt; Finland; France; Germany; Hong Kong; India; Indonesia; Ireland; Israel; Italy; Japan; Malaysia; Mexico; Netherlands; New Zealand; Nigeria; Norway; Peru; Philippines; Poland; Portugal; Romania; Russia; Saudi Arabia; Singapore; South Africa; South Korea; Spain; Sweden; Switzerland; Thailand; Turkey; UAE; UK; USA; Venezuela; Vietnam

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, cardiovascular drugs indicators comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Report Structure

3. Cardiovascular Drugs Market Characteristics

  • 3.1. Market Definition
  • 3.2. Key Segmentations

4. Cardiovascular Drugs Market Product Analysis

  • 4.1. Leading Products/ Services
  • 4.2. Key Features and Differentiators
  • 4.3. Development Products

5. Cardiovascular Drugs Market Supply Chain

  • 5.1. Supply Chain
  • 5.2. Distribution
  • 5.3. End Customers

6. Cardiovascular Drugs Market Customer Information

  • 6.1. Customer Preferences
  • 6.2. End Use Market Size and Growth

7. Cardiovascular Drugs Market Trends And Strategies

8. Cardiovascular Drugs Market Size And Growth

  • 8.1. Market Size
  • 8.2. Historic Market Growth, Value ($ Billion)
    • 8.2.1. Drivers Of The Market
    • 8.2.2. Restraints On The Market
  • 8.3. Forecast Market Growth, Value ($ Billion)
    • 8.3.1. Drivers Of The Market
    • 8.3.2. Restraints On The Market

9. Cardiovascular Drugs Market Regional Analysis

  • 9.1. Global Cardiovascular Drugs Market, 2019, By Region, Value ($ Billion)
  • 9.2. Global Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region
  • 9.3. Global Cardiovascular Drugs Market, Growth And Market Share Comparison, By Region

10. Cardiovascular Drugs Market Segmentation

  • 10.1. Global Cardiovascular Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Anti-Hypertensive Drugs

Hypolipidemics

Anti Thrombotics

Other Drugs For Cardiovascular Diseases (Congestive Heart Failure, Anti-Arrhythmic And Anti-Anginal Drugs)

  • 10.2. Global Cardiovascular Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Hospital Pharmacies

Retail Pharmacies/ Drug Stores

Others

  • 10.3. Global Cardiovascular Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Oral

Parenteral

Others

  • 10.4. Global Cardiovascular Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Branded Drugs

Generic Drugs

  • 10.5. Global Cardiovascular Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Prescription-Based Drugs

Over-The-Counter Drugs

11. Cardiovascular Drugs Market Metrics

  • 11.1. Cardiovascular Drugs Market Size, Percentage Of GDP, 2015-2023, Global
  • 11.2. Per Capita Average Cardiovascular Drugs Market Expenditure, 2015-2023, Global

12. Asia-Pacific Cardiovascular Drugs Market

  • 12.1. Asia-Pacific Cardiovascular Drugs Market Overview
  • 12.2. Asia-Pacific, Cardiovascular Drugs Market, 2019, By Country, Value ($ Billion)
  • 12.3. Asia-Pacific, Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 12.4. Asia-Pacific, Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 12.5. Asia-Pacific, Cardiovascular Drugs Market Metrics
    • 12.5.1. Per Capita Average Cardiovascular Drugs Expenditure, 2015-2023, Asia-Pacific Countries
  • 12.6. Asia-Pacific Cardiovascular Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 12.7. Asia-Pacific Cardiovascular Drugs Market: Country Analysis
    • 12.7.1. China Cardiovascular Drugs Market
      • 12.7.1.1. China Cardiovascular Drugs Market Overview
      • 12.7.1.2. China Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.1.3. China Cardiovascular Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.2. Australia Cardiovascular Drugs Market
      • 12.7.2.1. Australia Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.2.2. Australia Cardiovascular Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.3. Hong Kong Cardiovascular Drugs Market
      • 12.7.3.1. Hong Kong Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.4. India Cardiovascular Drugs Market
      • 12.7.4.1. India Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.4.2. India Cardiovascular Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.5. Indonesia Cardiovascular Drugs Market
      • 12.7.5.1. Indonesia Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.5.2. Indonesia Cardiovascular Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.6. Japan Cardiovascular Drugs Market
      • 12.7.6.1. Japan Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.6.2. Japan Cardiovascular Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.7. Malaysia Cardiovascular Drugs Market
      • 12.7.7.1. Malaysia Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.8. New Zealand Cardiovascular Drugs Market
      • 12.7.8.1. New Zealand Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.9. Philippines Cardiovascular Drugs Market
      • 12.7.9.1. Philippines Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.10. Singapore Cardiovascular Drugs Market
      • 12.7.10.1. Singapore Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.11. South Korea Cardiovascular Drugs Market
      • 12.7.11.1. South Korea Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.11.2. South Korea Cardiovascular Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.12. Thailand Cardiovascular Drugs Market
      • 12.7.12.1. Thailand Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.13. Vietnam Cardiovascular Drugs Market
      • 12.7.13.1. Vietnam Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

13. Western Europe Cardiovascular Drugs Market

  • 13.1. Western Europe Cardiovascular Drugs Market Overview
  • 13.2. Western Europe, Cardiovascular Drugs Market, 2019, By Country, Value ($ Billion)
  • 13.3. Western Europe, Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 13.4. Western Europe, Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 13.5. Western Europe, Cardiovascular Drugs Market Metrics
    • 13.5.1. Per Capita Average Cardiovascular Drugs Expenditure, 2015-2023, Western Europe Countries
  • 13.6. Western Europe Cardiovascular Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 13.7. Western Europe Cardiovascular Drugs Market: Country Analysis
    • 13.7.1. Austria Cardiovascular Drugs Market
      • 13.7.1.1. Austria Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.2. Belgium Cardiovascular Drugs Market
      • 13.7.2.1. Belgium Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.3. Denmark Cardiovascular Drugs Market
      • 13.7.3.1. Denmark Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.4. Finland Cardiovascular Drugs Market
      • 13.7.4.1. Finland Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.5. France Cardiovascular Drugs Market
      • 13.7.5.1. France Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 13.7.5.2. France Cardiovascular Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.6. Germany Cardiovascular Drugs Market
      • 13.7.6.1. Germany Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 13.7.6.2. Germany Cardiovascular Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.7. Ireland Cardiovascular Drugs Market
      • 13.7.7.1. Ireland Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.8. Italy Cardiovascular Drugs Market
      • 13.7.8.1. Italy Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.9. Netherlands Cardiovascular Drugs Market
      • 13.7.9.1. Netherlands Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.10. Norway Cardiovascular Drugs Market
      • 13.7.10.1. Norway Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.11. Portugal Cardiovascular Drugs Market
      • 13.7.11.1. Portugal Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.12. Spain Cardiovascular Drugs Market
      • 13.7.12.1. Spain Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.13. Sweden Cardiovascular Drugs Market
      • 13.7.13.1. Sweden Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.14. Switzerland Cardiovascular Drugs Market
      • 13.7.14.1. Switzerland Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.15. UK Cardiovascular Drugs Market
      • 13.7.15.1. UK Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 13.7.15.2. UK Cardiovascular Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

14. Eastern Europe Cardiovascular Drugs Market

  • 14.1. Eastern Europe Cardiovascular Drugs Market Overview
  • 14.2. Eastern Europe, Cardiovascular Drugs Market, 2019, By Country, Value ($ Billion)
  • 14.3. Eastern Europe, Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 14.4. Eastern Europe, Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 14.5. Eastern Europe, Cardiovascular Drugs Market Metrics
    • 14.5.1. Per Capita Average Cardiovascular Drugs Expenditure, 2015-2023, Eastern Europe Countries
  • 14.6. Eastern Europe Cardiovascular Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 14.7. Eastern Europe Cardiovascular Drugs Market: Country Analysis
    • 14.7.1. Czech Republic Cardiovascular Drugs Market,
      • 14.7.1.1. Czech Republic Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 14.7.2. Poland Cardiovascular Drugs Market
      • 14.7.2.1. Poland Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 14.7.3. Romania Cardiovascular Drugs Market
      • 14.7.3.1. Romania Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 14.7.4. Russia Cardiovascular Drugs Market
      • 14.7.4.1. Russia Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 14.7.4.2. Russia Cardiovascular Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

15. North America Cardiovascular Drugs Market

  • 15.1. North America Cardiovascular Drugs Market Overview
  • 15.2. North America, Cardiovascular Drugs Market, 2019, By Country, Value ($ Billion)
  • 15.3. North America, Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 15.4. North America, Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 15.5. North America, Cardiovascular Drugs Market Metrics
    • 15.5.1. Per Capita Average Cardiovascular Drugs Expenditure, 2015-2023, North America Countries
  • 15.6. North America Cardiovascular Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 15.7. North America Cardiovascular Drugs Market: Country Analysis
    • 15.7.1. Canada Cardiovascular Drugs Market
      • 15.7.1.1. Canada Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 15.7.2. Mexico Cardiovascular Drugs Market
      • 15.7.2.1. Mexico Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 15.7.3. USA Cardiovascular Drugs Market
      • 15.7.3.1. USA Cardiovascular Drugs Market Overview
      • 15.7.3.2. USA Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 15.7.3.3. USA Cardiovascular Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

16. South America Cardiovascular Drugs Market

  • 16.1. South America Cardiovascular Drugs Market Overview
  • 16.2. South America, Cardiovascular Drugs Market, 2019, By Country, Value ($ Billion)
  • 16.3. South America, Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 16.4. South America, Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 16.5. South America, Cardiovascular Drugs Market Metrics
    • 16.5.1. Per Capita Average Cardiovascular Drugs Expenditure, 2015-2023, South America Countries
  • 16.6. South America Cardiovascular Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 16.7. South America Cardiovascular Drugs Market: Country Analysis
    • 16.7.1. Argentina Cardiovascular Drugs Market
      • 16.7.1.1. Argentina Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 16.7.2. Brazil Cardiovascular Drugs Market
      • 16.7.1.1. Brazil Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 16.7.2.2. Brazil Cardiovascular Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 16.7.3. Chile Cardiovascular Drugs Market
      • 16.7.3.1. Chile Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 16.7.4. Colombia Cardiovascular Drugs Market
      • 16.7.4.1. Colombia Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 16.7.5. Peru Cardiovascular Drugs Market
      • 16.7.5.1. Peru Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 16.7.6. Venezuela Cardiovascular Drugs Market
      • 16.7.6.1. Venezuela Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

17. Middle East Cardiovascular Drugs Market

  • 17.1. Middle East Cardiovascular Drugs Market Overview
  • 17.2. Middle East, Cardiovascular Drugs Market, 2019, By Country, Value ($ Billion)
  • 17.3. Middle East, Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 17.4. Middle East, Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 17.5. Middle East, Cardiovascular Drugs Market Metrics
    • 17.5.1. Per Capita Average Cardiovascular Drugs Expenditure, 2015-2023, Middle East Countries
  • 17.6. Middle East Cardiovascular Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 17.7. Middle East Cardiovascular Drugs Market: Country Analysis
    • 17.7.1. Saudi Arabia Cardiovascular Drugs Market
      • 17.7.1.1. Saudi Arabia Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 17.7.2. Israel Cardiovascular Drugs Market
      • 17.7.2.1. Israel Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 17.7.3. Turkey Cardiovascular Drugs Market
      • 17.7.3.1. Turkey Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 17.7.4. UAE Cardiovascular Drugs Market
      • 17.7.4.1. UAE Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

18. Africa Cardiovascular Drugs Market

  • 18.1. Africa Cardiovascular Drugs Market Overview
  • 18.2. Africa, Cardiovascular Drugs Market, 2019, By Country, Value ($ Billion)
  • 18.3. Africa, Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 18.4. Africa, Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 18.5. Africa, Cardiovascular Drugs Market Metrics
    • 18.5.1. Per Capita Average Cardiovascular Drugs Expenditure, 2015-2023, Africa Countries
  • 18.6. Africa Cardiovascular Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 18.7. Africa Cardiovascular Drugs Market: Country Analysis
    • 18.7.1. Egypt Cardiovascular Drugs Market
      • 18.7.1.1. Egypt Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 18.7.2. Nigeria Cardiovascular Drugs Market
      • 18.7.2.1. Nigeria Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 18.7.3. South Africa Cardiovascular Drugs Market
      • 18.7.3.1. South Africa Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

19. Cardiovascular Drugs Market Competitive Landscape

  • 19.1. Competitive Market Overview
  • 19.2. Market Shares
  • 19.3. Company Profiles
    • 19.3.1. Merck & Co
      • 19.3.1.1. Company Overview
      • 19.3.1.2. Products And Services
      • 19.3.1.3. Strategy
      • 19.3.1.4. Financial Performance
    • 19.3.2. Sanofi S.A
      • 19.3.2.1. Company Overview
      • 19.3.2.2. Products And Services
      • 19.3.2.3. Strategy
      • 19.3.2.4. Financial Performance
    • 19.3.3. Pfizer Inc
      • 19.3.3.1. Company Overview
      • 19.3.3.2. Products And Services
      • 19.3.3.3. Strategy
      • 19.3.3.4. Financial Performance
    • 19.3.4. Bristol-Myers Squibb Company
      • 19.3.4.1. Company Overview
      • 19.3.4.2. Products And Services
      • 19.3.4.3. Strategy
      • 19.3.4.4. Financial Performance
    • 19.3.5. Novartis AG
      • 19.3.5.1. Company Overview
      • 19.3.5.2. Products And Services
      • 19.3.5.3. Strategy
      • 19.3.5.4. Financial Performance

20. Key Mergers And Acquisitions In The Cardiovascular Drugs Market

21. Market Background: Pharmaceutical Drugs Market

  • 21.1. Pharmaceutical Drugs Market Characteristics
  • 21.2. Pharmaceutical Drugs Market Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F Growth, By Segment, Value ($ Billion), Global
  • 21.3. Global Pharmaceutical Drugs Market, 2019, By Region, Value ($ Billion)
  • 21.4. Global Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region
  • 21.5. Global Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Segmentation By Type, Value ($ Billion)

22. Recommendations

  • 22.1. Global Cardiovascular Drugs Market In 2023- Growth Countries
  • 22.2. Global Cardiovascular Drugs Market In 2023- Growth Segments
  • 22.3. Global Cardiovascular Drugs Market In 2023- Growth Strategies

23. Appendix

  • 23.1. NAICS Definitions Of Industry Covered In This Report
  • 23.2. Abbreviations
  • 23.3. Currencies
  • 23.4. Research Inquiries
  • 23.5. The Business Research Company

24. Copyright And Disclaimer